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Alamethicin, a hydrophobic peptide that is considered a paradigm for membrane channel formation, was
uniformly labeled with 15N, reconstituted into oriented phosphatidylcholine bilayers at concentrations of 1 or
5 mol %, and investigated by solid-state NMR spectroscopy as a function of temperature. Whereas the peptide
adopts a transmembrane alignment in POPC bilayers at all temperatures investigated, it switches from a
transmembrane to an in-plane orientation in DPPC membranes when passing the phase transition temperature.
This behavior can be explained by an increase in membrane hydrophobic thickness and the resulting
hydrophobic mismatch condition. Having established the membrane topology of alamethicin at temperatures
above and below the phase transition, ESEEM EPR was used to investigate the water accessibility of alamethicin
synthetic analogues carrying the electron spin label TOAC residue at one of positions 1, 8, or 16. Whereas
in the transmembrane alignment the labels at positions 8 and 16 are screened from the water phase, this is
only the case for the latter position when adopting an orientation parallel to the surface. By comparing the
EPR and solid-state NMR data of membrane-associated alamethicin it becomes obvious that the TOAC spin
labels and the cryo-temperatures required for EPR spectroscopy have less of an effect on the alamethicin-POPC
interactions when compared to DPPC. Finally, at P/L ratios of 1/100, spectral line broadening due to spin-spin
interactions and thereby peptide oligomerization within the membrane were detected for transmembrane
alamethicin.
Introduction
Alamethicin is a 19-mer peptide, acetylated at the N-terminus
and extended with the 1,2-amino alcohol Phl at the C-terminus,
produced by the fungus Trichoderma Viride that generates a
voltage-dependent conductance in bilayers [reviewed in refs
1-4]. It is of interest both as a model for voltage-gated channels
and for the behavior of membrane-associated helices. Alame-
thicin is composed mostly of hydrophobic residues and adopts
apredominantlyhelicalstructureinmembrane-likeenvironments.5-7
The single-channel properties and the concentration dependence
of the conduction are consistent with various degrees of helix
oligomerization in the membrane.8,9
Alamethicin strongly associates with model membranes and
exhibits a cooperative binding to fluid phase phosphatidylcho-
lines as determined by both CD and EPR techniques.10,11 The
open alamethicin pore remains a paradigm for transmembrane
helical bundles or barrel staves, which is a model consistent
with the behavior of covalently linked alamethicin dimers.12
However, CW EPR measurements at room temperature of
C-terminally labeled alamethicin analogues failed to detect the
postulated oligomeric state.11,13,14
When membrane-associated alamethicin was investigated by
CD spectroscopy as a function of temperature, the data provided
evidence for the existence of two forms of the peptide that
interconvert as a function of peptide concentration.15 On the
basis of this observation and a large amount of additional
experimental data from oriented CD, neutron in-plane scattering,
and X-ray diffraction techniques,16-21 the two-state model has
been proposed.22 At low P/L ratios the peptide associates with
the membrane surface and inserts in a transmembrane fashion
above a threshold concentration.16 Correspondingly, a minimal
peptide concentration is required for antibiotic and channel
activities. Moreover, well-defined water-filled openings were
detected by neutron in-plane scattering in bilayers containing
transmembrane alamethicin.17
However, to our knowledge, direct alamethicin peptide
oligomerization has never been detected experimentally, and
the exact molecular structure of the pore remains speculative.
Therefore, advanced pulsed EPR methods (such as PELDOR
or DQC) have been developed and have proven their capacity
to access peptide oligomerization.23 Unfortunately, these ap-
proaches, as well as novel solid-state NMR spectroscopy DNP
signal enhancement techniques,24 are only applicable at cryo-
temperatures, where the lipid membranes are in the gel or subgel
phase, whereas at physiological conditions the membranes are
in the fluid phase.
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Here, we tested the influence of temperature and lipid
membrane phase on the alamethicin peptide topology when
bound to phospholipid membrane by oriented 15N solid-state
NMR spectroscopy and EPR ESEEM techniques. The first
technique can be applied at both ambient and reduced temper-
atures and provides a direct indication of the helix alignment
relative to the membrane normal.25,26 In contrast, the ESEEM
technique depends on cryo-temperatures but also provides
complementary information on the water exposure of the spin
labels.
Solid-state NMR spectroscopy has been used successfully
in the past to investigate the 3D-structure, topology, and
dynamics of many membrane polypeptides [reviewed in refs
27-30]. In particular, proton-decoupled 15N solid-state NMR
spectroscopy has been used to investigate the alignment of
helical polypeptides and their orientational distribution.
Whereas in oriented samples 15N chemical shifts >180 ppm
are indicative of transmembrane alignments of R-helices,
values <100 ppm are observed for amphipathic peptides
oriented with the helix axis parallel to the membrane
surface.25 Proton-decoupled 15N solid-state NMR spectros-
copy of macroscopically oriented samples has been success-
fully applied to alamethicin bound to POPC or DMPC
membranes at P/L molar ratios ranging from 1/8 to 1/237,
where thepredominantpeptideorientation is transmembrane.31-35
For the purpose of this study we extended these investigations
to gel-state PC membranes and to lipids that have been used
during EPR investigations. In this manner we were able to assess
the influence of low temperatures and, consequently, a change
in lipid membrane phase on the alamethicin peptide orientation
when bound to PC membranes. On the one hand, POPC is a
major component of eukaryotic membranes, exhibits a gel-to-
fluid transition temperature at 271 K, and therefore exists in
the fluid phase at room temperature. On the other hand, DPPC
is in the gel phase at ambient temperatures, with phase
transitions from fluid to ripple at 314.5 K, ripple to gel at 308
K, and gel to subgel at 280 K [reviewed in ref 36]. The phase
transition temperatures were slightly shifted and broadened upon
addition of alamethicin and salt,37 but for the present study these
effects are of minor importance.
ESEEM is a powerful method to study the access of water
molecules to the electron spin labeled sites and, in a fashion
complementary to the NMR approach, to determine the immer-
sion depth of spin-labeled peptides. The approach is based on
the dependence of anisotropic hyperfine interaction constants
of nitroxide spins on the proximity of hydrogens. When
deuterated water is used, the influence of water can be clearly
distinguished from that of lipid molecules. Furthermore, the
deuterons increase the amplitude of ESEEM at the X-band.
Since water molecules are less abundant in the hydrophobic
core of the membrane, the amplitude of the ESEEM spectrum
depends on the depth of the peptide label position relative to
the membrane surface. Comparison of these data obtained for
peptides analogues spin labeled at different positions provides
an indicator of peptide orientation. This method has been
successfully employed to study the membrane-bound state of
the peptaibol trichogin GA IV.38 In this work we used the solid-
state NMR data to compare the excitation profiles obtained by
the ESEEM technique at cryo-temperatures with regard to
helix-membrane interactions.
Materials and Methods
Materials. The solution synthesis and characterization of the
spin-labeled Glu(OMe)7,18,19 alamethicin F50/5 analogues Alm1,
Alm8, and Alm16 are described in ref 39. The biochemical
preparation of 15N uniformly labeled alamethicin (F50/7) has
been described previously40 and results in its uniform labeling
with 15N to more than 92%. The peptide sequences are:
Ac-Aib-Pro-Aib-Ala-Aib-Aib-Gln-Aib-Val-Aib-Gly-Leu-Aib-
Pro-Val-Aib-Aib-Gln-Gln-Phl (Alm)
Ac-TOAC1-Pro-Aib-Ala-Aib-Ala-Glu(OMe)-Aib-Val-Aib-
Gly-Leu-Aib-Pro-Val-Aib-Aib-Glu(OMe)-Glu(OMe)-Phl (Alm1)
Ac-Aib-Pro-Aib-Ala-Aib-Ala-Glu(OMe)-TOAC8-Val-Aib-
Gly-Leu-Aib-Pro-Val-Aib-Aib-Glu(OMe)-Glu(OMe)-Phl (Alm8)
Ac-Aib-Pro-Aib-Ala-Aib-Ala-Glu(OMe)-Aib-Val-Aib-Gly-
Leu-Aib-Pro-Val-TOAC16-Aib-Glu(OMe)-Glu(OMe)-Phl (Alm16)
The chemical structures of Aib and the TOAC label are shown
below:
As for alamethicin, the more easily synthesized γ-methyl Glu
analogs are also functional as channels and aggregate easily.41-43
The last step in the preparation of the Alm8 and Alm16
analogues involved crystallization from organic solvents. For
the Alm1 analogue it was lyophilization. So for Alm1, many
more water molecules could remain associated with the peptide,
thus resulting in a lower peptide content, and hence, radical
content, per sample.
All lipids were from Avanti Polar Lipids, Inc. (Alabaster,
AL). For the preparation of buffer solutions, reagent grade
chemicals and deuterated water (D2O) were obtained from
Sigma-Aldrich (St. Louis, MO). All commercial products were
used without further purification.
Sample Preparation for EPR. To prepare homogeneous
mixtures of lipids and peptides, these components were first
codissolved in chloroform. The solvent was then evaporated
with a stream of nitrogen gas and thereafter by exposure to high
vacuum for at least 3 h. The mixture was dispersed in PBS
buffer by vortex mixing well-above the phase transition tem-
perature of the membranes (i.e., at 328 K for DPPC and at room
temperature for POPC membranes). The hydrated lipid bilayers
were briefly sonicated in a bath sonicator (for more homoge-
neous mixing) and subjected to five rapid freeze-thaw cycles,
centrifuged, and concentrated by pelleting in a benchtop
centrifuge. After removal of the excess buffer the final water
concentration was about 50% w/w. Following this procedure,
nonoriented MLVs were obtained.
Sample Preparation for NMR. A homogeneous mixture of
lipid and peptide was obtained by codissolving the membrane
components in chloroform. To prepare POPC membranes, the
solution was spread onto ultra thin cover glasses (9 × 22 mm,
Marienfeld, Lauda-Ko¨nigshofen, Germany), dried first in air or
a stream of nitrogen gas and thereafter in high vacuum
overnight. For DPPC the protocol was slightly modified to be
most closely related to the one used for the preparation of EPR
samples. Again, a homogeneous mixture of [U-15N]-Alm and
30 mg of DPPC was first obtained in chloroform, and the solvent
was evaporated. Thereafter, 0.2 mL of milliQ water were added,
and the resulting suspension was vortexed and sonicated in a
bath for 5 min at 55 °C. The resulting milky suspension was
loaded onto 25 glass plates, and the water was evaporated in
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air and in high vacuum. A small amount (50 µL) of 10 mM
Tris buffer (pH 7.5) was equally distributed onto the glass plates.
Both the POPC and DPPC membranes were equilibrated at 93%
relative humidity. Where necessary, the hydration of the samples
was increased by exposure to higher temperatures and 100%
relative humidity for 2 h (328 K for DPPC and 310 K for DMPC
membranes) before the glass slides were stacked on top of each
other.
EPR Spectroscopy. ESEEM experiments were performed
on a Bruker ESP 380E pulse X-band EPR spectrometer. A
homemade rectangular resonator was used, with a quartz Dewar
containing liquid nitrogen. The resonator was overcoupled to
obtain a dead time of 100 ns. To improve the signal-to-noise
ratio, the three pulse-stimulated echo (π/2-τ-π/2-t1-π/2-τ-echo)
with microwave pulse widths of 16 ns and the microwave power
adjusted accordingly was used. The time delay t1 between the
second and the third pulse was incremented while maintaining
the separation τ between the first and the second pulse constant
at 200 ns to maximize the deuterium modulation. A four-step
phase-cycling program was employed to eliminate unwanted
echoes.
The time-dependent echo amplitudes, V(τ,T), were processed
to yield standardized ESEEM intensities, according to the
previously developed protocol.44 The average experimental echo
decay, 〈V(τ,T)〉, was obtained as a smooth function by fitting
ln(V(τ,T)) with a polynomial or a bilinear form. The normalized
ESE decay was then obtained as:
A complex Fourier transform of this normalized time-domain
signal was evaluated numerically as in eq 2,
where νk ) k/(N∆T) with k )-N/2 to +N/2, and T0 is a starting
time delay between the second and the third pulse in the
stimulated echo pulse sequence. The real and imaginary Fourier
coefficients were then used to obtain the absolute-value ESEEM
spectrum. Although the discrete Fourier transform software
supplied with the ELEXSYS FT-EPR spectrometer does not
take into account different dwell times, ∆T, in determining
amplitudes of the ESEEM spectrum, evaluation according to
eq 2 provides spectrometer-independent densities, with the
dimensions of time, which can be used for comparing different
D2O-containing systems. The calibration curve representing
ESEEM amplitudes for lipids spin-labeled at different positions
along the hydrocarbon side chain44 are presented in Supporting
Information Figure S1.
Conventional, continuous-wave EPR spectra were recorded
on a Bruker ESP 380E X-band EPR spectrometer with 100 kHz
field modulation and 1 G modulation amplitude. A Bruker
rectangular resonator was used, with a quartz Dewar containing
liquid nitrogen (77 K).
NMR Spectroscopy. Proton-decoupled 31P solid-state NMR
spectra were acquired at 161.953 MHz on a Bruker Avance
widebore 400 NMR spectrometer equipped with a double
resonance flat-coil probe.45 A phase cycled Hahn-echo pulse
sequence46 with a π/2 pulse of 2.5 µs, a spectral width of 75
kHz, an echo delay of 40 µs, and a recycle delay of 3 s was
used. Spectra were referenced externally to 85% H3PO4 at 0
ppm.
Proton-decoupled 15N CP spectra of static aligned samples
were acquired at 40.54 MHz on a Bruker Avance widebore 400
NMR spectrometer equipped with a double resonance flat-coil
probe.45 An adiabatic CP pulse sequence47 was used with a
spectral width, acquisition time, CP contact time, and recycle
delay time of 75 kHz, 3.5 ms, 0.5 ms, and 3 s, respectively.
The 1H π/2 pulse and spinal 64 heteronuclear decoupling field
strengths were 42 kHz. 40 k scans were accumulated, and the
spectra were zero filled to 4096 points. Typically, a 100 Hz
exponential line-broadening was applied before Fourier trans-
formation. Spectra were externally referenced to 15NH4Cl at 41.5
ppm. An Oxford temperature control unit was used.
Results
Alamethicin Topology As a Function of Temperature and
Membrane Lipid Composition by Solid-state NMR. Figure
1 shows proton-decoupled 15N CP spectra of uniformly 15N
labeled alamethicin reconstituted into POPC (E, F) and DPPC
(G-J) membranes oriented with the normal of the glass plates
parallel to the external magnetic field direction and at peptide
concentrations of 1 mol %. The DPPC sample was included in
this study as it permits the investigation of the effect of gel
phase lipids on alamethicin topology at the same ambient
temperature also used for the more physiologically relevant
fluid-phase POPC membrane. Solid-state NMR spectra were
recorded as a function of temperature. Panels (A) and (D)
represent proton-decoupled 31P solid-state NMR spectra of both
samples acquired at room temperature.
The proton-decoupled 31P spectrum of POPC (Figure 1A)
exhibits one narrow peak at 28 ppm, indicative of highly
oriented liquid crystalline lipid bilayers. The proton-decoupled
15N spectrum of [U-15N]-alamethicin exhibits signal intensities
predominantly in the 190-230 ppm range (Figure 1E). These
chemical shift values correlate with transmembrane orientations
of helical peptides.25
The spectrum of the same sample recorded at 248 K, that is,
below the fluid-to-gel transition temperature of POPC (271 K),
is shown in Figure 1F. Although the line is broadened when
compared to the room-temperature spectrum (Figure 1E), the
chemical shift values indicate that alamethicin remains trans-
membrane in gel-phase POPC bilayers. The 31P spectrum of
oriented POPC lipid bilayers clearly indicates that the lipid
membrane is well-oriented also at a temperature of 248 K
(Figure 1B).
The proton-decoupled 31P spectrum of the gel-phase DPPC
membranes at room temperature exhibits a much broader line
width and shows spectral intensities ranging from -35 to +40
ppm (Figure 1D). This result strongly suggests that the alignment
of the DPPC headgroups is not as homogeneous as in the case
of liquid crystalline POPC membranes at the same temperature.
The proton-decoupled 15N spectrum of 15N labeled alamethicin
when bound to DPPC bilayers (Figure 1H) exhibits all signal
intensities in the 60-120 ppm region, indicative of helix
alignments perpendicular to the magnetic field direction.25
When the temperature is increased to 333 K, the 31P spectrum
of this sample reveals well-oriented fluid-phase DPPC bilayers
(Figure 1C). At this temperature the maximum of the 15N signal
intensity shifts to about 200 ppm (Figure 1G) showing that the
peptide predominantly adopts transmembrane orientations in
fluid-phase DPPC bilayers. Cooling the same sample to 248 or
223 K, that is, well below the gel-to-subgel phase transition
Vn(τ, T) ) V(τ, T)/〈V(τ, T)〉 - 1 (1)
I(νk) ) ∆T∑
j)0
N
Vn(τ, To + j∆T)exp(-i2πνk(T0 + j∆T))
(2)
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temperature for DPPC (280 K), results in the spectra reported
in Figures 1I,J. Some broadening is observed when compared
to the spectrum obtained at room temperature, and the chemical
shift values are indicative of surface orientations of the peptide
also under these conditions.
Measurements of the Alamethicin Membrane Penetration
by Pulsed EPR at 77 K. ESEEM Spectroscopy. The ESEEM
technique was used to monitor water accessibility and peptide
orientation relative to the membrane surface. To enhance the
relaxation times of the electron spins, this technique requires
recording of the spectra at reduced temperatures, and the
ESEEM spectra shown in Figure 2 were therefore recorded at
77 K.
When applied to POPC membranes, the modulus Fourier-
transform ESEEM spectra shown in Figure 2A are obtained.
The peak intensity is most pronounced for the label at position
1, and labels at position 8 and 16 are on average buried deeper
in the membrane, thereby lowering the signal intensity. A
transmembrane alignment was observed for alamethicin in
POPC gel-phase by proton-decoupled 15N solid-state NMR
spectroscopy (Figure 1E), and the ESEEM data are suggestive
that this topology persists also at 77 K.
The ESEEM spectra of TOAC-labeled alamethicin analogues
when bound to POPC membranes remain unaffected by the
peptide concentration within the range of P/L molar ratios 1/100
(Figure 2A) to 1/20 (not shown). This finding agrees with
investigations of POPC-associated alamethicin, labeled uni-
formly with 15N using proton-decoupled 15N solid-state NMR
spectroscopy, where transmembrane alignments were found at
P/L ratios of 1/15, 1/100, and 1/237 [Figures 1E, F and refs 31
and 35].
Figure 2B shows the modulus Fourier-transform ESEEM
spectra of paramagnetically labeled alamethicin analogues in
DPPC membranes at a P/L molar ratio 1:275. Similar data were
obtained at P/L molar ratios ranging from 1:275 to 1:50 (not
shown). In contrast to POPC membranes, the peak intensity for
Alm8 is more pronounced when compared to the Alm1 or
Alm16 analogues, indicating that the label at position 8 is closest
to the membrane surface, whereas labels at positions 1 and 16
are buried deeper in the bilayer. These results agree well with
the in-plane alignment that was observed by solid-state NMR
spectroscopy of 15N uniformly labeled alamethicin reconstituted
into subgel phase DPPC (Figures 1I,J). It should be noted that
the quantitative comparison of the peak intensities observed for
different membranes (namely, DPPC and POPC) is not straight-
forward, but the peptide orientation in POPC membranes is
clearly different from the one observed in DPPC.
When the alamethicin concentration in DPPC was increased
from 1/50 to 1/20 (Figures 2B and 2C) the labels at positions
8 and 16 become less water-accessible, but at the same time
the signal of the Alm1 label remains unaffected (Figure 2C).
Overall, the ESEEM spectra shown in Figure 2C resemble more
closely those of alamethicin reconstituted into POPC membranes
(Figure 2A). When an alamethicin/DPPC 1/20 sample deposited
onto glass slides is investigated by solid-state NMR spectroscopy
at room temperature, both the 31P NMR signal (Figure 3A) of
the phospholipids and the 15N spectrum (Figure 3B,C) of the
peptide chain are indicative of considerable loss in membrane
orientational order (Figure 3).
CW EPR Spectroscopy. CW EPR spectra at 77 K of TOAC-
labeled alamethicin analogues bound to lipid membranes at two
different concentrations are shown in Figure 4. As at this
temperature regime peptide diffusion in the membrane is
suppressed, the spectral line width provides an indicator of
spin-spin interactions. When alamethicin is reconstituted into
DPPC membranes the line widths are similar for all peptide
analogues investigated at P/L ratios ranging from 1:275 (Figure
4B) to 1:50 (not shown).
In contrast, the CW EPR spectra at 77 K of TOAC-labeled
alamethicin analogues bound to POPC membrane at a 1:100
P/L molar ratio are characterized by line widths that are a
function of the label position (Figure 4A). Whereas the lines
are broadened for position 8, the label at position 1 exhibits a
line width comparable to the one observed after reconstitution
into DPPC membranes. The signal arising from position 16
exhibits an intermediate CW EPR line width.
CW EPR spectra at 77 K for TOAC-labeled alamethicin
analogs in DPPC at 1/20 P/L molar ratio are shown in Figure
4C. The line-broadening is more pronounced for the label at
Figure 1. Proton-decoupled solid-state 31P (A-D) and 15N (E-J) NMR
spectra of alamethicin labeled uniformly with 15N reconstituted into
uniaxially oriented POPC membranes (A, E, F) at a P/L ratio of 1/100
and a temperature of (A, E) 294 K and (F) 248 K; and in DPPC
membranes (C, D, G-J) at a P/L ratio of 1/100 and a temperature of
(C, G) 333 K, (D, H) 294 K, (I) 248 K, and (J) 223 K. A line-broadening
of 300 Hz was applied before Fourier transformation for the spectra
on panels B, G, and J. Spectrum B was obtained from pure POPC
bilayers at a temperature of 248 K.
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position 8, even when compared to alamethicin reconstituted
into POPC (Figure 4A). To facilitate direct comparison, the CW
spectra of alamethicin in POPC at a P/L molar ratio of 1/100
(Figure 4A) are retraced using dotted lines in Figure 4C.
Discussion
Whereas the transmembrane alignment of alamethicin in
POPC at room temperature has already been documented,31,35
its persistence in the gel-phase of the same phospholipid has
not been observed previously. Furthermore, the topology of
alamethicin and, in particular, its in-plane alignment when
interacting with gel-phase DPPC membranes have, to our
knowledge, not been reported so far. The ESEEM investigations
(Figure 2B) qualitatively confirm the solid-state NMR data
(Figure 1H,I) and provide evidence that alamethicin prevails in
the surface-oriented state at peptide concentrations of 1 mol %
in gel-phase DPPC, well below the liquid crystalline-gel phase
transition.
Oriented solid-state NMR spectroscopy has also been used
to investigate the transmembrane alignment of alamethicin in
DMPC bilayers at P/L molar ratios of 1/8.32-34 Furthermore,
using oriented CD spectroscopy, neutron in-plane scattering,
and X-ray diffraction techniques, topological phase diagrams
of alamethicin in DPhPC, DOPC, and DPhPE have been
established as a function of membrane hydration, temperature,
and P/L ratio.16,17,48,49 Whereas at low alamethicin concentrations
the peptides are oriented parallel to the membrane surface, they
adopt transmembrane alignments and produce well-defined
water-filled pores at high P/L ratios. This finding has been
explained by the thinning of the membrane in the presence of
in-plane oriented peptides and by the resulting strain on the
membrane.18,20,50 From these observations, the two-state model,
that is, an equilibrium between in-plane and transmembrane
alamethicin, has been postulated where the transition to the
transmembrane topology occurs above a lipid-dependent critical
P/L ratio.22 For DOPC bilayers, which are of comparable
thickness as the POPC membranes, the reported threshold occurs
at e0.5 mol % of alamethicin,16 which is in good agreement
with the transmembrane alignments observed at peptide con-
centrations of 1 mol % (Figure 1E). Related models where
Figure 2. Modulus Fourier-transform ESEEM spectra for TOAC-labeled alamethicin analogues in lipid membrane at different P/L molar ratios.
(A) POPC P/L ratio of 1:100, (B) DPPC P/L ratio of 1:275, and (C) DPPC P/L ratio of 1:20. The dotted lines in panel C represent the spectra shown
in panel B to facilitate comparison. The location of the nitroxide moieties at positions 1 and 8 are superimposed on the X-ray diffraction structure
of alamethicin carrying a TOAC16 label and Glu(OMe) at positions 7, 18, and 19.42 Although a positioning of the molecule at the membrane
interface as illustrated agrees well with the data shown in panel B, other conformations, arrangements, and/or a conformational heterogeneity are
possible.
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similar types of transitions are responsible for voltage-gating
of the channels had been suggested even earlier [reviewed in
refs 3 and 51]
Matching the hydrophobic thickness of the membrane and
the length of the hydrophobic region of the peptide has been
found to be a main requirement for the stable transmembrane
insertion of peptaibols.31 However, other contributions, such as
the hydrophobic moment of the peptide or its effects on the
lipid fatty acyl chains, are also important.3,31 The X-ray
crystallographic structure of alamethicin exhibits a predomi-
nantly R-helical conformation that is 29 Å long.42,52 The
structural data for alamethicin in membrane-like environments
are indicative of a relatively stable helix at the N-terminus but
a more disordered and flexible C-terminus.5,53,54 Therefore, this
value should only be taken as a rough estimate for the
hydrophobic length of the membrane-associated structure.
Furthermore, the hydrophobic distance can be shortened, for
example, by tilting the helix relative to the membrane normal
or by kinks in the structure.7 On the other hand, it can be
elongated by adopting other conformations such as the
310-helix.31,35,55
In the fluid phase, the hydrophobic thickness of DPPC and
POPC membranes are 27 Å, a value also observed for DOPC
and egg-PC.56 Interestingly, alamethicin adopts predominantly
transmembrane alignments in both systems (Figures 1E-G).
When switching to DPPC gel or subgel phases, alamethicin
adopts in-plane orientations (Figure 1H-J). This effect is
correlated with the reported increase in the hydrophobic
thickness of DPPC to 34.4 Å.56 Whereas in gel-phase DPPC
the 15N data indicate that the peptide is well oriented (Figure
1H), the lipid head groups are aligned in a more heterogeneous
fashion (Figure 1D) and could, among other possibilities, be
explained by structures of toroidal shape.57 An increase of the
hydrophobic thickness in the gel phase seems to be a common
feature of bilayers composed of saturated lipid chains.56 In
contrast, the transmembrane orientation of alamethicin persists
in gel-phase POPC membranes. The constant d-spacing of POPC
bilayers when the gel phase (<265.6 K) and the fluid phase
(>275 K) are compared to each other58 suggests that the
temperature-dependent changes in membrane hydrophobic
thickness are less pronounced for the saturated-monounsaturated
POPC bilayers.
A strong dependence of peptide topology on the hydrophobic
matching conditions has previously been observed for the 16-
residue peptaibol zervamicin II,31 albeit a detailed comparison
with alamethicin suggests additional contributions from the
hydrophobic moment of the helices. Furthermore, hydrophobic
model sequences adopt stable transmembrane alignments when
the peptide is up to 3 Å too short or up to 14 Å too long to
match the pure bilayer. These sequences exhibit in-plane
alignments when too short and membrane disordering properties
when their length much exceeds the hydrophobic thickness of
the bilayers.59 A two-state transition when switching from fluid
to gel phase was observed for gramicidin A in DPPC and was
explained with hydrophobic mismatch effects.60
By comparing the data on the water-exposure of the TOAC
labels obtained from ESEEM at 77 K with those from 15N solid-
state NMR spectroscopy at low temperatures, it is possible to
test if the bulky electron spin-labels used in EPR have an effect
on the lipid-peptide interactions. Furthermore, by combining
both techniques it is feasible to investigate peptide topology
over a large range of temperatures (77-333 K).
It should also be noted that the two techniques provide highly
complementary information. Whereas the oriented solid-state
NMR techniques allow one to measure accurate angular
constraints, including tilt and rotational pitch angles in a direct
manner,34,35,61,62 the ESEEM technique provides information on
water accessibility of the labeled sites and therefore also on
membrane penetration depth. Other EPR techniques have been
used to investigate the aggregation state of membrane-associated
polypeptides (Figure 3 and refs 38 and 63) and are sensitive to
spin-spin interactions within a range of 65 Å.23 Nuclear spin
interactions, like dipolar couplings, can also be used to this end,
but they reach over shorter distances, e15 Å [reviewed in refs
64, 65]. Although solid-state NMR techniques can be performed
at very low temperatures, for example, see ref 66, our NMR
probes for oriented biomembrane samples are not designed to
this purpose.45 As the NMR sample size has, for sensitivity
reasons, to be considerably increased when compared to EPR,
it can be quite demanding to thermally isolate the electronic
circuit of the NMR probe from the sample area. In contrast,
the spin relaxation of the paramagnetic labels prevents EPR
investigations from being performed at biologically relevant
Figure 3. Proton-decoupled solid-state 31P (A) and 15N (B, C) NMR
spectra of alamethicin uniformly labeled with 15N and reconstituted
into DPPC membranes deposited onto glass plates at a P/L molar ratio
of 1/20. The spectra were recorded at room temperature with (A, B)
the glass plates oriented with their normal parallel to external magnetic
field and (B) perpendicular to the magnetic field direction.
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(ambient) temperatures. Indeed, we have shown here that
alamethicin adopts different topologies in liquid crystalline and
gel-state DPPC membranes. However, the POPC bilayer offers
itself for the study by either technique as the topological
arrangement is, at least qualitatively, unaffected by the bilayer
phase transition nor by the TOAC spin labels at the three
different positions of the peptide chain. In summary, the two
techniques provide highly complementary information covering
a large temperature range.
In addition, the direct comparison of oriented solid-state NMR
and EPR data has allowed us for the first time to unambiguously
identify the ESEEM signature for transmembrane (Figure 2A)
and in-plane oriented alamethicin (Figure 2B). Whereas the label
at position 1 is always exposed to the water phase, the
transmembrane alignment of alamethicin exhibits little water
accessibility throughout the central and C-terminal regions of
the sequence (Alm8 and Alm16). The signature of the peak
intensities in Figure 2A seems to indicate that water accessibility
to these central labels is very limited, suggesting a restricted
channel volume and/or a mixture of monomers, small noncon-
ducting and larger aggregates, rather than a homogeneous
population of large water-filled channels. Within the in-plane
oriented helix (Figure 2B), the exposure of individual residues
alters with the helical pitch, thereby exposing Alm8 to the water
phase but hiding Alm16 in the membrane interior (see the model
in Figure 2).
It remains possible that at the high peptide concentrations
shown in Figure 2C allow such large water-filled cavities or
other types of aggregate form. The ESEEM profile observed in
this case seems to reflect a degree of water accessibility for
Alm8 intermediate to the situations shown in Figures 2A and
2B. In this context it is interesting to note that gel-phase
alamethicin/DPPC membranes at P/L ratios of 1/20 exhibit
inhomogeneous alignments when investigated by 15N or 31P
solid-state NMR spectroscopy (Figure 3), indicating that the
peptide disorders the membranes at elevated concentrations.
Atomic force microscopy applied to mica-supported gel-phase
DPPC membranes in the presence of alamethicin P/L ratios of
1/25 or 1/100 reveals the presence of large openings involving
hundreds of peptides with domains of liquid crystalline mem-
branes lining the defects.37,67 In contrast, well-aligned NMR
spectra were obtained previously for alamethicin at elevated
concentrations in liquid crystalline DMPC or POPC membranes
at ambient temperatures.31-34
It should be noted that the water exposure of the label at
position 1 seems to contradict an earlier report where CW power
saturation EPR was applied to nitroxide-labeled alamethicin in
egg-PC.68 In this study the C-terminus was water-exposed with
positions 15 and 9 buried at 1 Å and 11.7 Å from the bilayer
surface, respectively. It was calculated that in such an arrange-
ment the N-terminus remains buried deep inside the membrane.68
The differences in amino acid sequences [analogues of alame-
Figure 4. CW EPR spectra of TOAC-labeled alamethicin analogues at 77 K. (A) in POPC at 1:100, (B) in DPPC at 1:275, and (C) in DPPC at
1:20 P/L molar ratios. CW EPR spectra for the corresponding alamethicin analogues bound to POPC membrane at a P/L ratio of 1:275 (panel A)
are shown by the dotted line. It should be noted that the peptide concentrations of the Alm1 samples may have been overestimated (cf. Materials
and Methods).
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thicin-F50/5 vs analogues of F50/7; see ref 4 for nomenclature],
in lipid (20 mM of 50 nm SUVs of egg-PC vs a pellet of MLVs
of POPC), in P/L ratio (e1/500 vs 1/100, addition of peptide
after or before vesicle formation), in pH (6.5 vs 7.5), or in
temperature (room temperature vs 77 K) can all be responsible
for the observed differences. In a related manner, the differences
between the topology observed in this work and the one
measured in a study using a variety of optical methods69
probably reflect the characteristics of the peptide derivatives
and the variations in experimental conditions. Furthermore, it
cannot be excluded that the spin-labels themselves affect such
a sensitive topological equilibrium and thereby the peptide
insertion into the membrane. Finally, the peptide might disrupt
the membrane packing and allow access of water from both
sides.
Having established the alignment and water exposure of
alamethicin, we investigated the membrane-associated peptide
by CW EPR at 77 K. In the absence of diffusion, the line width
of the EPR signals monitor the dipole-dipole interactions
between labeled sites and thus their proximity to one another.70
The dipolar line-broadening theory that has been developed for
the analysis of CW EPR spectra71 indicates that the line height
ratio d1/d (Figure 4A) can be used to assess the interaction
strength. Whereas d1/d ratios e0.4 are characteristic for non-
interacting spins, the values observed for Alm8 and Alm16 when
bound to POPC membrane at P/L ratios of 1/100 are 0.75 and
0.61, respectively (Figure 4A). Therefore, this result is indicative
of dipolar broadening and the existence of aggregated or
oligomeric states. The different line broadenings of the labeled
positions under identical conditions can be explained, for
example, by tilted arrangements of the helices and/or with a
kink in the structure.5,7,53,54 In this manner it is possible that the
Alm8 positions would be close to each other, whereas the Alm16
residues are further removed.
In contrast, alamethicin in DPPC at 1 mol % concentrations
exhibits d1/d ratios in the 0.40-0.42 range (Figure 4B)
independent of the P/L ratio (in the range 1/275 to 1/50),
indicating interspin distances g23 Å.71 It is interesting to note
that the broadened CW EPR lines correlate with the experi-
mental conditions where transmembrane topologies are observed
for alamethicin. This effect is even more pronounced when the
alamethicin sample is reconstituted into DPPC membranes at
elevated P/L ratios (Figure 4C), but due to the membrane
disordering observed for this sample, interpretation of the spectra
remains difficult (Figure 3).
In recent studies the influence of gel- and subgel-phase DPPC,
DMPC,and DSPC lipids on the conformation and oligomeriza-
tion of the membrane-modifying peptide gramicidin A was
monitored by CW EPR and DQC EPR methods.60 A change of
the peptide conformation in DPPC and DSPC membranes when
switching from the fluid to the gel phase was observed. In
contrast, in the case of DMPC, the conformation of membrane-
bound gramicidin A remains constant in the range 77-333 K,
a temperature range covering several membrane phases. The
results were interpreted in terms of match/mismatch between
hydrophobic length of the peptide and hydrophobic thickness
of bilayers.
Unfortunately, a detailed analysis of the CW EPR spectra in
terms of accurate distances and/or aggregation number would
depend on a number of assumptions and can, therefore, not be
performed reliably. However, self-oligomerization of alamethi-
cin was observed in frozen egg-PC membranes using the
PELDOR technique with an oligomer size of 4.63 The distance
distribution for Alm16 was characterized by a broad Gaussian
distribution (13 Å wide at half-height) with a maximum at a
distance of 23 Å.
In conclusion, our investigations indicate a more stable
transmembrane alignment of alamethicin in POPC when com-
pared to DPPC. For the latter bilayer, a switch from a
transmembrane alignment to an in-plane disposition has been
observed when entering the gel phase. This effect can be
explained by the increase in hydrophobic bilayer thickness by
about 6 Å and by the resulting hydrophobic mismatch between
the bilayer and the peptide. Whereas the DPPC membranes are
therefore not suited to obtain biologically relevant data on the
interaction of this peptide with membranes using EPR ap-
proaches, the topology of alamethicin remains unchanged, at
least on a qualitative level, when passing the phase transition
temperature of POPC membranes. In addition, the ESEEM
technique provides information on the water accessibility and,
therefore, membrane penetration depth of the peptides. By
comparing the EPR and the NMR techniques, characteristic
ESEEM signatures for transmembrane and surface-oriented
alamethicin could be identified. The line broadening observed
in CW EPR spectra suggests oligomerization of the transmem-
brane peptide.
Abbreviations Used
Aib R-aminoisobutyric acid.
CD circular dichroism.
CP cross polarization.
CW EPR continuous wave EPR.
DOPC 1,2-dioleoyl-sn-glycero-3-phosphocholine.
DMPC 1,2-myristoyl-sn-glycero-3-phosphocholine.
DNP dynamic nuclear polarization.
DPhPC 1,2-diphytanoyl- sn-glycero-3-phosphocholine.
DPhPE 1,2-diphytanoyl- sn-glycero-3-phosphoethanolamine.
DPPC 1,2-dipalmitoyl- sn-glycero-3-phosphocholine.
DSPC 1,2-stearoyl-sn-glycero-3-phosphocholine.
DQC double quantum coherence.
EPR electron paramagnetic resonance.
ESEEM electron spin echo envelope modulation.
MLV multilamellar vesicles.
NMR nuclear magnetic resonance.
OMe methoxy.
PBS phosphate buffered saline.
PC phosphatidylcholine.
Phl phenylalaninol.
PELDOR pulsed electron-electron double resonance.
P/L peptide-to-lipid.
POPC 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine.
SUV small unilamellar vesicles.
TOAC 4-amino-1-oxyl-2,2,6,6-tetramethylpiperidine-4-car-
boxylic acid.
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positions along the hydrocarbon side chain normalized according
to eqs 1 and 2 [adapted from ref 44]. This material is available
free of charge via the Internet at http://pubs.acs.org.
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